Wellington Management Group’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
Other funds holding DRUG
Wellington Management Group's DRUG Position: Q3 2026 in Review
Wellington Management Group increased its Bright Minds Biosciences (DRUG) stake by 29% in Q3 2026, buying an estimated $3.53M and bringing the position to 221,361 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.
Wellington Management Group first reported a position in DRUG in Q4 2025 and has held it in 4 quarters since. The position peaked at $12M in Q2 2026. 110 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.
- Wellington Management Group held 221,361 shares of Bright Minds Biosciences worth $11M as of Q3 2026.
- Wellington Management Group bought 50,046 Bright Minds Biosciences shares in Q3 2026, an estimated $3.53M.
- Bright Minds Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1243 holding.
- Wellington Management Group first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 4 quarters since.
- Wellington Management Group's Bright Minds Biosciences position peaked at $12M in Q2 2026.
- 110 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.